Structural insights into antibody-based immunotherapy for hepatocellular carcinoma
Abstract Hepatocellular carcinoma (HCC) is one of the most common types of primary liver cancer and remains a leading cause of cancer-related deaths worldwide. While traditional approaches like surgical resection and tyrosine kinase inhibitors struggle against the tumor’s immune evasion, monoclonal...
Saved in:
Main Authors: | Masaud Shah, Muhammad Hussain, Hyun Goo Woo |
---|---|
Format: | Article |
Language: | English |
Published: |
BioMed Central
2025-01-01
|
Series: | Genomics & Informatics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s44342-024-00033-0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Design of a humanized CD40 agonist antibody with specific properties using AlphaFold2 and development of an anti-PD-L1/CD40 bispecific antibody for cancer immunotherapy
by: Kun Du, et al.
Published: (2025-02-01) -
BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA
by: Ugo Testa, et al.
Published: (2024-08-01) -
Advancing Multiple Myeloma Immunotherapy: A Review of Chimeric Antigen Receptor T-Cell and Bispecific T-Cell Engagers Cell Therapies in Revolutionizing Treatment
by: Rahul Navab, et al.
Published: (2025-01-01) -
Antibody-epitope conjugates deliver immunogenic T-cell epitopes more efficiently when close to cell surfaces
by: W. van der Wulp, et al.
Published: (2024-12-01) -
Gut Microbiome Modulation in Hepatocellular Carcinoma: Preventive Role in NAFLD/NASH Progression and Potential Applications in Immunotherapy-Based Strategies
by: Elisa Monti, et al.
Published: (2025-01-01)